Adynovate Special Drug Use Result Survey (Perioperative Administration)
Latest Information Update: 28 Mar 2024
At a glance
- Drugs Rurioctocog alfa pegol (Primary)
- Indications Haemophilia A
- Focus Adverse reactions
- Sponsors Takeda
- 10 Jan 2024 Status changed from active, no longer recruiting to completed.
- 03 Sep 2023 Planned End Date changed from 31 Jan 2023 to 31 Dec 2023.
- 03 Sep 2023 Planned primary completion date changed from 31 Jan 2023 to 31 Dec 2023.